Loading...
Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
Paclitaxel is a first line chemotherapeutic agent for the patients with metastatic breast cancer. But inherited or acquired resistance to paclitaxel leads to poor response rates in a majority of these patients. To identify mechanisms of paclitaxel resistance, we developed paclitaxel resistant breast...
Saved in:
| Published in: | Sci Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6434141/ https://ncbi.nlm.nih.gov/pubmed/30911062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-41632-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|